Traditional medicine has been an integral source of accessible healthcare to different communities around the globe. While modern medicine's bureaucratic approach in pharmaceutical-based healing has been the gold standard for centuries, alternative medication is the hallmark for diverse sustainable development and continuously evolving research. According to WHO, an estimated 88% of all countries around the world still use traditional medicine up to this day, from acupuncture, herbal medicines, indigenous therapies, to yoga.
As the industry continues to break grounds and introduce new nature-based remedies, the global market of traditional medicine is at a skyrocketing trajectory worth $135 billion in 2022, and continues to soar at a projected $178 billion by 2026.
One of the companies that have made a significant breakthrough in gastrointestinal remedy is Evinature, a leading cutting-edge research in integrative therapies for IBD. Founders Prof. Shomron Ben-Horin M.D., Nir Salomon, andApan Amos Damri have sourced, developed, and distributed clinically-proven nutraceuticals to provide patients with global access to accurate diagnosis and treatment through our proprietary online platform. Their discovery of curcumin as a reliever of intestinal inflammation broke boundaries and has particularly drawn interest as a treatment for Crohn's Disease and ulcerative colitis.
Clinically Validated Natural Remedies
In 2011, Nir Salomon, integrative medical expert, joined forces with Professor Shomron Ben-Horin to confirm curcumin as an effective treatment for IBD. Their highly successful four-year placebo-controlled study was published in a top global medical journal and led to the inclusion of curcumin in the ECCO Practice Position Statements - a trailblazing milestone for natural medicine.
After the success of their trial, Salomon, Ben-Horin and Apan Amos Damri founded Evinature with the mission to promote clinically validated natural remedies that are safe and effective. Their patient-focused platform offers integrative strategies, guided care from a collective of integrative and gastrointestinal experts, in-depth and up-to-date research, and vital information from patient's data.
Evinature was founded by connecting two medical philosophies. By bridging the gap between modern and traditional medicine, their team is able to provide more patients with safe and natural remedies that are embraced by the medical community. Today, the Evinature platform guides patients through the CurQDTM Protocol, natural, tailored treatment regimes. Since then, The CurQDTM Protocol has been implemented into standard clinical practice in some of Israel's leading medical centers and has transformed the way IBD treatment for patients.
The Evinature Standard
Evinature prioritizes evidence above the trends. Their team emphasizes product quality and scientific integrity above all else, exclusively distributing products that have passed through the golden standard of clinical trials. Their standard includes: peer reviewed, double-blind, placebo-controlled, integrated in world leading medical centers, published in high impact medical journals, and consistent results across medical centers.
Evinature is constantly evolving and refining their products through research. Their team is welcoming patients to participate by reviewing newly developed products. The founders recognize that each patient contributes to the community simply by taking the assessment and submitting reports. This allows us to constantly expand our collective knowledge and keep the community updated with vital news and information.
* This is a contributed article and this content does not necessarily represent the views of sciencetimes.com
